Top Markets
#1 0G 0G +45.73%
#2 Merlin's Seal BTC Merlin's Seal BTC +42.87%
#3 Useless Coin Useless Coin +30.72%
#4 SAFEcoin SAFEcoin +28.84%
#5 Dogs Dogs +24.05%
#6 Pons Pons +24.05%
#7 StonkBroker StonkBroker +21.73%
#8 ICON ICON +20.45%
#9 Zora Zora +20.32%
#10 Dash Dash +17.58%
Coin of the day
0G 0G
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Impact Therap-b Impact Therap-b

Impact Therap-b

7630
Classifica tra le azioni #13196
IMPACT Therapeutics, a biotechnology firm, specializes in the discovery and... IMPACT Therapeutics, a biotechnology firm, specializes in the discovery and advancement of precision anti-cancer treatments rooted in synthetic lethality, operating across China and international markets. The company's primary offering, Senaparib (IMP4297), is a PARP1/2 inhibitor currently deployed as a first-line maintenance therapy for ovarian cancer. Beyond this, Impact Therapeutics maintains a robust pipeline of investigational drugs. This includes IMP1734, a next-generation PARP1 selective inhibitor undergoing Phase I/II trials as a standalone treatment for advanced solid tumors. Another promising candidate is IMP9064, an ATR kinase selective inhibitor, also in Phase I/II clinical studies for advanced solid tumors as a monotherapy. IMP1707, a PARP1 selective inhibitor capable of penetrating the central nervous system, is in Phase I development for homologous recombination repair-deficient tumors. Additionally, IMP7068, an advanced WEE1 inhibitor, is progressing through Phase I/II clinical trials for various advanced solid tumors. Furthermore, a range of other compounds, namely IMP22, IMP25, IMP08, IMP13, IMP10, IMP27, and IMP32, are in the preclinical development phase. The company, established in 2009, is headquartered in Shanghai, China.
Prezzo delle azioni
$1.85
Capitalizzazione di mercato
$510.85M
Variazione (1 giorno)
-7.37%
Variazione (1 anno)
-
Paese
CN
Scambia Impact Therap-b (7630)

Categoria

Healthcare
Cronologia dei frazionamenti azionari per Impact Therap-b (7630)
L’azione Impact Therap-b (simbolo: 7630) ha subito un totale di 0 frazionamenti.
L’ultimo frazionamento è avvenuto il Aug 31, 2026.
Una quota di 7630 acquistata prima di Aug 31, 2026 equivale oggi a 0 quote di 7630.
Elenco dei frazionamenti azionari
Anno Frazionamento Moltiplicatore Moltiplicatore cumulativo
Non abbastanza dati per le date fornite.
Frazionamenti azionari di aziende simili o concorrenti
Azienda Numero di frazionamenti azionari Moltiplicatore cumulativo Il paese
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 4 x15
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 7 x432
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 0 -
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 2 x10000
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 7 x226
US